Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Sep 7, 2028 (in 694 days)
Similar opportunities open now
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Apr 2027
- NCMRR Early Career Research Award (R03 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028Up to $200K
- Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses May 2028
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Jan 7, 2027 (in 85 days)Up to $375K
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses May 2027
Classification and identifiers
- Solicitation number
- PAR-25-324
- Assistance listing (CFDA)
- 93.393
Amount
Amount not listed here. Check the official program.
Who can apply
Public colleges and universities and Private colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments: